MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 -
Germany
This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
{
"resourceType" : "Observation",
"id" : "MII-EXA-MTB-Response-Befund-Beispiel-1",
"meta" : {
"profile" : [
🔗 "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-response-befund|2027.0.0-ballot.1"
]
},
"language" : "de",
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"de\" lang=\"de\"><hr/><p><b>German</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: Observation MII-EXA-MTB-Response-Befund-Beispiel-1</b></p><a name=\"de-MII-EXA-MTB-Response-Befund-Beispiel-1\"> </a><a name=\"de-hcMII-EXA-MTB-Response-Befund-Beispiel-1\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mii-pr-mtb-response-befund.html\">MII PR MTB Response Befund</a> version: 2027.0.0-ballot.1</p></div><p><b>partOf</b>: <a href=\"Procedure-MII-EXA-MTB-Systemtherapie-Beispiel-1.html\">Procedure Zytostatische Chemotherapie, Immuntherapie und antiretrovirale Therapie</a></p><p><b>status</b>: Registered</p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 396432002}\">Status of regression of tumor (observable entity)</span></p><p><b>subject</b>: <a href=\"Patient-mii-exa-mtb-patient.html\">Maxim Muster (no stated gender), DoB Unknown</a></p><p><b>focus</b>: <a href=\"Condition-mii-exa-mtb-kim-diagnose.html\">Condition Bösartige Neubildung: Peritoneum, nicht näher bezeichnet</a></p><p><b>effective</b>: 2014-02-12</p><p><b>value</b>: <span title=\"Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/CodeSystem/mii-cs-mtb-response-befund-beurteilung PD}\">Progressive Disease</span></p><p><b>method</b>: <span title=\"Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/CodeSystem/mii-cs-mtb-response-befund-beurteilungsmethode RECIST}\">RECIST</span></p><h3>Components</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 445200009}\">Status of residual neoplasm (observable entity)</span></td><td><span title=\"Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-verlauf-primaertumor K}\">Kein Tumor nachweisbar</span></td></tr></table></div>"
},
"partOf" : [
{
🔗 "reference" : "Procedure/MII-EXA-MTB-Systemtherapie-Beispiel-1"
}
],
"status" : "registered",
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "396432002",
"display" : "Status of regression of tumor (observable entity)"
}
]
},
"subject" : {
🔗 "reference" : "Patient/mii-exa-mtb-patient"
},
"focus" : [
{
🔗 "reference" : "Condition/mii-exa-mtb-kim-diagnose"
}
],
"effectiveDateTime" : "2014-02-12",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/CodeSystem/mii-cs-mtb-response-befund-beurteilung",
"code" : "PD",
"display" : "Progressive Disease"
}
]
},
"method" : {
"coding" : [
{
"system" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/CodeSystem/mii-cs-mtb-response-befund-beurteilungsmethode",
"code" : "RECIST",
"display" : "RECIST"
}
]
},
"component" : [
{
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "445200009",
"display" : "Status of residual neoplasm (observable entity)"
}
]
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-verlauf-primaertumor",
"code" : "K",
"display" : "Kein Tumor nachweisbar"
}
]
}
}
]
}